L-dopa in neurological disease: current status.
D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D002526:Cerebellar Diseases / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D003704:Dementia / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy; D009103:Multiple Sclerosis / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine